58 related articles for article (PubMed ID: 17943721)
1. HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
Ha SA; Shin SM; Lee YJ; Kim S; Kim HK; Namkoong H; Lee H; Lee YS; Cho YS; Park YG; Jeon HM; Oh C; Kim JW
Int J Cancer; 2008 Feb; 122(3):501-8. PubMed ID: 17943721
[TBL] [Abstract][Full Text] [Related]
2. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
[TBL] [Abstract][Full Text] [Related]
3. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
[TBL] [Abstract][Full Text] [Related]
5. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
[TBL] [Abstract][Full Text] [Related]
7. Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.
Ha SA; Lee YS; Shin SM; Kim HK; Kim S; Namkoong H; Kim HJ; Jung SM; Lee YS; Chung YJ; Jung SS; Kim JW
BMC Cancer; 2009 Feb; 9():51. PubMed ID: 19208263
[TBL] [Abstract][Full Text] [Related]
8. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
9. Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity.
Ha SA; Shin SM; Kim HK; Kim S; Namkoong H; Lee YS; Kim HJ; Jung SM; Lee YS; Chung YJ; Park YG; Jung SS; Kim JW
J Cell Mol Med; 2009 Sep; 13(9B):3868-75. PubMed ID: 20196787
[TBL] [Abstract][Full Text] [Related]
10. The HCCR oncoprotein as a biomarker for human breast cancer.
Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the interaction of the regulatory protein Ki-1/57 with p53 and its interacting proteins.
Nery FC; Rui E; Kuniyoshi TM; Kobarg J
Biochem Biophys Res Commun; 2006 Mar; 341(3):847-55. PubMed ID: 16455055
[TBL] [Abstract][Full Text] [Related]
12. Transdifferentiation-inducing HCCR-1 oncogene.
Ha SA; Kim HK; Yoo J; Kim S; Shin SM; Lee YS; Hur SY; Kim YW; Kim TE; Chung YJ; Jeun SS; Kim DW; Park YG; Kim J; Shin SY; Lee YH; Kim JW
BMC Cell Biol; 2010 Jun; 11():49. PubMed ID: 20591135
[TBL] [Abstract][Full Text] [Related]
13. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells].
Yang Y; Zhou XF; Liu AD
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
15. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
16. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
17. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
[TBL] [Abstract][Full Text] [Related]
19. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
